ArticleInternational journal of nanomedicine2018

Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells.

Sanjay SinghPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.